Navigation Links
AMA Applauds House Committee Passage of Tobacco Regulation Bill; Calls for Full House Passage
Date:4/2/2008

WASHINGTON, April 2, 2008 /PRNewswire-USNewswire/ -- The following statement was issued today by AMA President Ron Davis, M.D.:

"The American Medical Association applauds the U.S. House Energy and Commerce Committee for passing the "Family Smoking Prevention and Tobacco Control Act." The AMA urges the full House to take a critical step to combat smoking-related diseases by passing the bill this year, giving the FDA needed regulatory authority over tobacco products.

"Given what we know about the dangers of smoking, it is astonishing that tobacco products are one of the least regulated products in our society. The time is now for Congress to pass legislation to regulate the tobacco industry and protect the health of Americans, particularly our nation's youth. The bill will stop illegal sales of tobacco products to children, further restrict marketing, especially to kids, and require more informative package health warnings.

"The FDA currently serves a vital role in protecting the health of Americans through the regulation of food and drugs. This bill ensures that the FDA will have the resources necessary to regulate the tobacco industry in addition to its current responsibilities."


'/>"/>
SOURCE American Medical Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. American Lung Association Applauds Energy and Commerce Committee for its Strong Commitment to Protecting Public Health From the Dangers of Tobacco
2. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
3. SCAI Applauds CMS Decision to Continue Coverage of Cardiac CT Scans
4. AAHSA Applauds Medicare Payment Advisory Commissions (MedPAC) Draft Recommendations for Revising the Skilled Nursing Facility (SNF) Payment System
5. AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008
6. Home Oxygen Community Applauds Senator Johnny Isakson for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
7. Home Oxygen Community Applauds Senator George Voinovich for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
8. Home Oxygen Community Applauds Senator Barbara Mikulski for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
9. Home Oxygen Community Applauds Senators Olympia Snowe and Susan Collins for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
10. Home Oxygen Community Applauds Senator Bernard Sanders for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
11. Home Oxygen Community Applauds Senator Kit Bond for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam 2Health News:Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam 3Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 5Health News:Registered Dietitians Identify Diet 'Gaps' - and How to Handle Them 2Health News:Registered Dietitians Identify Diet 'Gaps' - and How to Handle Them 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 2Health News:Nutraceutical Reports Fiscal 2009 Year End Results 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 4Health News:Nutraceutical Reports Fiscal 2009 Year End Results 5Health News:Nutraceutical Reports Fiscal 2009 Year End Results 6Health News:Nutraceutical Reports Fiscal 2009 Year End Results 7Health News:Nutraceutical Reports Fiscal 2009 Year End Results 8Health News:Fastrack Announces Major Expansion 2Health News:Fastrack Announces Major Expansion 3
Breaking Medicine Technology:Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 2Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 4Springer launches SpringerImages 9172 1Springer launches SpringerImages 9172 2Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting 51101 1Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting 51101 2American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 1American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 2American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 3
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 2RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 3